Hisayuki Katsuyama

Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial

S. Kahl, Sofiya Gancheva, Klaus Straßburger et al. · Diabetes Care · 2019 · 323 citations · Full text

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 300 citations

Non-pharmacological Intervention, Diabetes Management, Cardiovascular Disease +9

Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice

Atsushi Obata, Naoto Kubota, Tetsuya Kubota et al. · Endocrinology · 2015 · 144 citations · Full text

Nutrition, Metabolic Disorder, Caloric Restriction +23

Association of handgrip strength with hospitalization, cardiovascular events, and mortality in Japanese patients with type 2 diabetes

Hidetaka Hamasaki, Yu Kawashima, Hisayuki Katsuyama et al. · Scientific Reports · 2017 · 98 citations · Full text

TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass

Iseki Takamoto, Naoto Kubota, Keizo Nakaya et al. · Diabetologia · 2013 · 86 citations · Full text

Molecular Physiology, Signal Transduction, Beta Cell Mass +10